SynCardia Systems Acquired by Versa Capital Management, LLC
September 20, 2016
SynCardia Systems, LLC (“SynCardia” or the “Company”), maker of the SynCardia temporary Total Artificial Heart (TAH-t), today successfully completed its previously announced reorganization process and has been acquired by affiliates of investment firm Versa Capital Management, LLC (“Versa”). SynCardia will continue to be headquartered in Tucson, Ariz., and led by President and CEO Michael P. Garippa.
Young Bride Blessed With 2nd Chance at Life, Thanks to the SynCardia Artificial Heart
September 6, 2016
The SynCardia temporary Total Artificial Heart (TAH-t) saved Danielle Weston’s life, a life that would have been cut short by heart failure.
Three weeks of support from the SynCardia Artificial Heart helped Weston accomplish her dreams—earn a college degree, establish a career and have a family. In short, she got a second chance at the full life she came very close to losing.
SynCardia Artificial Heart to Emerge from Chapter 11 Reorganization With New Owner on September 16, 2016
August 16, 2016
“SynCardia’s machine works quite well, but it’s a very old machine with a big air compressor … I’m not surprised that they’re heading out of the market,” said Marcello Conviti.
SynCardia states it is not heading out of the market that it dominates through superior clinical results. Here are the facts on SynCardia’s reorganization:
News Update: After 555 Days On The SynCardia Artificial Heart, Stan Larkin Is Now At Home With His Donor Heart
June 22, 2016
On June 10, 2016, Stan Larkin, 25, was discharged from the University of Michigan Frankel Cardiovascular Center with a donor heart after living with the SynCardia temporary Total Artificial Heart for 18 months, according to a University of Michigan spokesperson.
Man Without a Human Heart Becomes Mr. Fix-It, Takes Road Trips & Hunts
June 8, 2016
Robert “Bob” Coyle, a successful Hollywood set construction supervisor in Los Angeles, was in and out of hospitals for close to two decades trying to manage his heart failure. Finally, when all other treatments failed, he turned to the SynCardia Total Artificial Heart (TAH-t) to save his life.
Eight of The Best Total Artificial Heart Centers Honored by SynCardia
May 10, 2016
The eight honored SynCardia Certified centers were presented awards during the 36th Annual Meeting of the International Society of Heart & Lung Transplantation (ISHLT), April 27-30, 2016, in Washington D.C. The awards were not part of the ISHLT official program.
Pat’s Run: ‘Tin Man’ Completes 3rd Consecutive Run Without His Native Heart
May 3, 2016
As a teenager, an active and athletic Randy Shepherd twice contracted rheumatic fever, which damaged his heart. He continued enjoying sports and recreation throughout his life.
10 Scientific Presentations on the SynCardia temporary Total Artificial Heart Will Be Given at The International Society for Heart & Lung Transplantation’s 36th Annual Meeting
April 22, 2016
The 36th Annual Meeting of the ISHLT will be held at the Marriott Wardman Park Hotel in Washington D.C. April 27-30, 2016.
The SynCardia Total Artificial Heart is the only approved device in use that, like a heart transplant, eliminates the source of end-stage biventricular (both sides) heart failure.
World’s Leading Artificial Heart Center, La Pitié Hospital, Paris, Celebrates 30 Years and 249 Implants of the SynCardia Total Artificial Heart
April 13, 2016
Prof. Christian Cabrol implanted the first Total Artificial Heart in France on Sunday, April 13, 1986 at La Pitié- Salpêtrière Hospital. He also performed the first heart transplant in Europe (1968) and the first heart-lung transplant (1982). The leadership and work of La Pitié’s Cabrol, Prof. Alain Pavie and Prof. Pascal Leprince are recognized worldwide for their major contributions to cardiac surgery and patient care.
Le plus grand établissement de transplantation cardiaque au monde, l'hôpital La Pitié, à Paris, fête 30 années de travaux et 249 implantations du cœur artificiel total de SynCardia
13 avril 2016
C'est le dimanche 13 avril 1986 à l'hôpital La Pitié-Salpêtrière, en France, que le Professeur Christian Cabrol a implanté le premier cœur artificiel total. C'est également lui qui a réalisé la première transplantation cardiaque en Europe (1968) et la première transplantation coeur-poumons (1982). Le leadership et les travaux des professeurs Cabrol, Alain Pavie et Pascal Leprince de La Pitié sont salués à travers le monde pour leur apport important à la chirurgie cardiaque et aux soins des patients.
New York Times Posts Retro Report Documentary: The Total Artificial Heart - From 1st Implant to World’s Most Used Artificial Heart
March 21, 2016
Learn the history and modern use of the SynCardia temporary Total Artificial Heart (TAH-t) from the world premiere 12-minute Retro Report documentary, “A Change of Heart,” which re-examines this leading story of the past and brings you through to today’s news.
Early Findings of the 50cc SynCardia Heart Indicate That It Fits Underserved Patients – Women & Adolescents
February 29, 2016
SynCardia Systems, Inc. announced that between December 2014 through Wednesday, February 24, 2016, 23 patients (70% female, compared to the historical average of only 12% for the larger 70cc TAH-t) have been implanted with the new 50cc SynCardia temporary Total Artificial Heart (TAH-t).